Non-immune hydrops fetalis was rare in Sweden during 1997-2015, but cases were associated with complications and poor prognosis
- PMID: 32187745
- DOI: 10.1111/apa.15260
Non-immune hydrops fetalis was rare in Sweden during 1997-2015, but cases were associated with complications and poor prognosis
Abstract
Aim: The study was designed to document the incidence of non-immune hydrops fetalis (NIHF) at birth and characterise associated outcomes and obstetric complications.
Methods: Data on more than 1.9 million births were extracted from the Swedish Birth Register for 1997-2015. Pregnancies not affected by NIHF served as controls. National registers on mortality and hospitalisations provided follow-up information.
Results: There were 309 cases of NIHF at birth corresponding to an incidence of 1.6 per 10 000, lower than in previous studies. NIHF was more frequent in mothers aged ≥35 years and with a history of stillbirth. Preterm delivery occurred in 77.7% in the NIHF group, including 31.7% before 32 weeks of gestation. Multiple births and Caesarean sections were reported more frequent in the NIHF group. NIHF was associated with poor outcome with 14.6% stillbirths and in 26.5% early neonatal death. Overall, 58.7% of live-born children with NIHF were alive at 12 months compared with 99.7% of controls. The most common causes of death were cardiovascular diseases and thoracic abnormalities.
Conclusion: NIHF at birth is associated with obstetric complications and poor prognosis for the neonate related to underlying disease. The low incidence of NIHF observed in this study may reflect well-developed antenatal care.
Keywords: incidence; non-immune hydrops fetalis; obstetric complications; poor prognosis; population study.
© 2020 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
Similar articles
-
Non-Immune Hydrops Fetalis: Do Placentomegaly and Polyhydramnios Matter?J Ultrasound Med. 2018 May;37(5):1185-1191. doi: 10.1002/jum.14462. Epub 2017 Oct 27. J Ultrasound Med. 2018. PMID: 29076544 Free PMC article.
-
Maternal outcomes of a cohort of pregnancies affected by non-immune hydrops fetalis.Int J Gynaecol Obstet. 2024 Apr;165(1):318-327. doi: 10.1002/ijgo.15207. Epub 2023 Oct 27. Int J Gynaecol Obstet. 2024. PMID: 37897049
-
Nonimmune hydrops fetalis in a children's hospital: a six-year series.Singapore Med J. 2013 Sep;54(9):487-90. doi: 10.11622/smedj.2013169. Singapore Med J. 2013. PMID: 24068055
-
[Non-immune hydrops fetalis. Review of 11 cases].An Esp Pediatr. 1988 Jan;28(1):43-7. An Esp Pediatr. 1988. PMID: 3279886 Review. Spanish.
-
Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature.Orphanet J Rare Dis. 2012 Nov 8;7:86. doi: 10.1186/1750-1172-7-86. Orphanet J Rare Dis. 2012. PMID: 23137060 Free PMC article. Review.
Cited by
-
Diagnostic yield using whole-genome sequencing and in-silico panel of 281 genes associated with non-immune hydrops fetalis in clinical setting.Ultrasound Obstet Gynecol. 2022 Oct;60(4):487-493. doi: 10.1002/uog.24911. Epub 2022 Aug 30. Ultrasound Obstet Gynecol. 2022. PMID: 35397126 Free PMC article.
-
Spontaneous resolution of nonimmune hydrops fetalis in a fetus with TP63 gene mutation and LZTR1 gene variants.Clin Case Rep. 2021 Aug 10;9(8):e04624. doi: 10.1002/ccr3.4624. eCollection 2021 Aug. Clin Case Rep. 2021. PMID: 34401172 Free PMC article.
-
Diagnostic value of congenital pulmonary airway malformation volume ratio for fetal hydrops due to congenital lung malformations: a systematic review and meta-analysis.Orphanet J Rare Dis. 2022 Jun 3;17(1):213. doi: 10.1186/s13023-022-02347-0. Orphanet J Rare Dis. 2022. PMID: 35658911 Free PMC article.
-
Lysosomal storage disorders in nonimmune hydrops fetalis diagnosed by exome sequencing.Orphanet J Rare Dis. 2025 Jul 10;20(1):351. doi: 10.1186/s13023-025-03851-9. Orphanet J Rare Dis. 2025. PMID: 40640912 Free PMC article. Review.
-
Etiology and perinatal outcomes between early and late-onset nonimmune hydrops fetalis.Rev Assoc Med Bras (1992). 2024 Jul 19;70(7):e20231723. doi: 10.1590/1806-9282.20231723. eCollection 2024. Rev Assoc Med Bras (1992). 2024. PMID: 39045931 Free PMC article.
References
REFERENCES
-
- Norton ME, Chauhan SP, Dashe JS. Society for Maternal-Fetal Medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol. 2015;212:127-139.
-
- Trainor B, Tubman R. The emerging pattern of hydrops fetalis-incidence, aetiology and management. Ulster Med J. 2006;75:185-186.
-
- Zwiers C, Oepkes D, Lopriore E, Klumper FJ, de Haas M, van Kamp IL. The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization. Prenat Diagn. 2018;38:943-950.
-
- Steurer MA, Peyvandi S, Baer RJ, et al. Epidemiology of live born infants with nonimmune hydrops fetalis-insights from a population-based dataset. J Pediatr. 2017;187:182-188.e3.
-
- Wafelman LS, Pollock BH, Kreutzer J, Richards DS, Hutchison AA. Nonimmune hydrops fetalis: fetal and neonatal outcome during 1983-1992. Biol Neonate. 1999;75:73-81.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources